| Megan Eichmeier, ARNP, PMHNP | |
|
9 North 4th Avenue, Marshalltown, IA 50158 | |
| (641) 752-1585 | |
| (641) 752-9665 |
| Full Name | Megan Eichmeier |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 9 North 4th Avenue, Marshalltown, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437645272 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | G122991 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Eichmeier, ARNP, PMHNP 9 N 4th St, Marshalltown, IA 50158-5709 Ph: (641) 752-1585 | Megan Eichmeier, ARNP, PMHNP 9 North 4th Avenue, Marshalltown, IA 50158 Ph: (641) 752-1585 |
News Archive
Amgen today announced a Phase 3 study evaluating the efficacy and safety of biosimilar candidate ABP 501 compared with Humira® (adalimumab) in patients with moderate-to-severe rheumatoid arthritis met its primary and key secondary endpoints.
An analysis of the phase III NRG Oncology clinical trial RTOG 9601 on men receiving salvage radiotherapy (SRT) following prostatectomy for recurrent prostate cancer indicated that, while biochemical failure (BF) was not a strong surrogate endpoint to determine overall survival (OS), metastasis-free survival (MFS) was in this patient population.
A jury in a U.S. District Court in Little Rock, Ark., on Friday dismissed negligence charges in the first of about 5,000 lawsuits filed over Prempro, a combination hormone replacement therapy manufactured by Wyeth, and found the drug's design was not defective, Reuters reports.
In 2005 the international community made an historic commitment to achieve universal access to HIV prevention, treatment and care by 2010 at the Group of Eight (G8) summit in Gleneagles, Scotland. Despite important progress, the world is not yet on track to achieve this commitment, and there are troubling signs that donors and implementing countries are capping or shrinking funding for the HIV response.
The U.S. Food and Drug Administration announced on Oct. 27 that it has approved, for the first time, an oncolytic (cancer-killing) viral therapy in the United States. The drug was approved for use against late-stage melanoma, a deadly skin cancer that can be difficult to treat.
› Verified 4 days ago
Mrs. Kristina Lucia Beck, ARNP, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1301 Summit St, Marshalltown, IA 50158 Phone: 641-891-7271 | |
Gail Marie Dooley, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 26 S 1st Ave Ste 100, Marshalltown, IA 50158 Phone: 641-753-2150 Fax: 641-753-2509 | |
Cindy S Cruikshank, N.P. Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 412 E Church St, Marshalltown, IA 50158 Phone: 641-753-4021 Fax: 641-753-4025 | |
Marilyn Harter, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 412 E Church St, Marshalltown, IA 50158 Phone: 641-753-4021 Fax: 641-753-4025 | |
Christine M Schmitt, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 55 Central Iowa Dr, Marshalltown, IA 50158 Phone: 641-854-8550 | |
Brach Rene Jones, ARNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 312 E Main St Ste 1000, Marshalltown, IA 50158 Phone: 641-752-5469 Fax: 641-844-2205 | |
Carol B Barlow, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 421 E Merle Hibbs Blvd, Marshalltown, IA 50158 Phone: 641-752-5469 Fax: 641-844-2205 |